Dana Farber Cancer Institute
Andrew Lu is a medical student at Weill Cornell Medicine and the Tri-Institutional MD-PhD program. He studied at Harvard College where he developed biomaterials for enhancing immune cell therapy approaches and earned a bachelor of science degree in bioengineering. In 2024, he joined the lab of Dr. Matthew Davids at the Dana Farber Cancer Institute where he investigated CAR-NK cells as a treatment strategy for chronic lymphocytic leukemia.
